Based in Israel, Evozyne is a startup. Brouky records 2 investors associated with the company.
Evozyne is a biotechnology company that uses generative AI combined with high-throughput biology to design and build engineered therapeutic proteins. The company focuses on creating novel protein therapeutics for immune-mediated diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.